- Home
- NPWR vs FENC Comparison
NPWR vs FENC Comparison
Compare NPWR & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- FENC
- Stock Information
- Founded
- NPWR 2010
- FENC 1996
- Country
- NPWR United States
- FENC United States
- Employees
- NPWR N/A
- FENC N/A
- Industry
- NPWR Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPWR Energy
- FENC Health Care
- Exchange
- NPWR Nasdaq
- FENC Nasdaq
- Market Cap
- NPWR 285.1M
- FENC 234.9M
- IPO Year
- NPWR N/A
- FENC 2001
- Fundamental
- Price
- NPWR $2.70
- FENC $8.71
- Analyst Decision
- NPWR Buy
- FENC Strong Buy
- Analyst Count
- NPWR 2
- FENC 2
- Target Price
- NPWR $3.50
- FENC $13.50
- AVG Volume (30 Days)
- NPWR 1.9M
- FENC 131.1K
- Earning Date
- NPWR 11-13-2025
- FENC 11-13-2025
- Dividend Yield
- NPWR N/A
- FENC N/A
- EPS Growth
- NPWR N/A
- FENC N/A
- EPS
- NPWR N/A
- FENC N/A
- Revenue
- NPWR N/A
- FENC $38,790,000.00
- Revenue This Year
- NPWR N/A
- FENC N/A
- Revenue Next Year
- NPWR N/A
- FENC $64.79
- P/E Ratio
- NPWR N/A
- FENC N/A
- Revenue Growth
- NPWR 42.86
- FENC N/A
- 52 Week Low
- NPWR $1.48
- FENC $3.96
- 52 Week High
- NPWR $14.12
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- NPWR 35.66
- FENC 56.14
- Support Level
- NPWR $2.22
- FENC $7.53
- Resistance Level
- NPWR $3.42
- FENC $9.00
- Average True Range (ATR)
- NPWR 0.34
- FENC 0.48
- MACD
- NPWR -0.13
- FENC 0.07
- Stochastic Oscillator
- NPWR 25.20
- FENC 80.27
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.